Global IVF Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR112403998

Publication Date:

November 28, 2024

Pages:

103

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global IVF market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2鈥�6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
The report includes an overview of the development of the IVF industry chain, the market status of Clone (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER)), Transgenic (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVF.
Regionally, the report analyzes the IVF markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVF market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVF market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVF industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVF market.
Regional Analysis: The report involves examining the IVF market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVF market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVF:
Company Analysis: Report covers individual IVF players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVF This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clone, Transgenic).
Technology Analysis: Report covers specific technologies relevant to IVF. It assesses the current state, advancements, and potential future developments in IVF areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVF market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVF market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)
Market segment by Application
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby
Market segment by players, this report covers
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IVF product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVF, with revenue, gross margin and global market share of IVF from 2019 to 2024.
Chapter 3, the IVF competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVF market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVF.
Chapter 13, to describe IVF research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of IVF
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVF by Type
1.3.1 Overview: Global IVF Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IVF Consumption Value Market Share by Type in 2023
1.3.3 Intracytoplasmic Sperm Injection (ICSI)
1.3.4 Frozen Embryo Replacement (FER)
1.3.5 Pre-implantation Genetic Diagnosis (PGD)
1.4 Global IVF Market by Application
1.4.1 Overview: Global IVF Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clone
1.4.3 Transgenic
1.4.4 Embryonic Stem Cell Isolation and Culture
1.4.5 Test Tube Baby
1.5 Global IVF Market Size & Forecast
1.6 Global IVF Market Size and Forecast by Region
1.6.1 Global IVF Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IVF Market Size by Region, (2019-2030)
1.6.3 North America IVF Market Size and Prospect (2019-2030)
1.6.4 Europe IVF Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IVF Market Size and Prospect (2019-2030)
1.6.6 South America IVF Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IVF Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Vitrolife AB
2.1.1 Vitrolife AB Details
2.1.2 Vitrolife AB Major Business
2.1.3 Vitrolife AB IVF Product and Solutions
2.1.4 Vitrolife AB IVF Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Vitrolife AB Recent Developments and Future Plans
2.2 EMD Serono Inc
2.2.1 EMD Serono Inc Details
2.2.2 EMD Serono Inc Major Business
2.2.3 EMD Serono Inc IVF Product and Solutions
2.2.4 EMD Serono Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 EMD Serono Inc Recent Developments and Future Plans
2.3 Irvine scientific
2.3.1 Irvine scientific Details
2.3.2 Irvine scientific Major Business
2.3.3 Irvine scientific IVF Product and Solutions
2.3.4 Irvine scientific IVF Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Irvine scientific Recent Developments and Future Plans
2.4 Cooper Surgical Inc
2.4.1 Cooper Surgical Inc Details
2.4.2 Cooper Surgical Inc Major Business
2.4.3 Cooper Surgical Inc IVF Product and Solutions
2.4.4 Cooper Surgical Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cooper Surgical Inc Recent Developments and Future Plans
2.5 Cook Medical Inc
2.5.1 Cook Medical Inc Details
2.5.2 Cook Medical Inc Major Business
2.5.3 Cook Medical Inc IVF Product and Solutions
2.5.4 Cook Medical Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cook Medical Inc Recent Developments and Future Plans
2.6 Thermo Fisher Scientific Inc
2.6.1 Thermo Fisher Scientific Inc Details
2.6.2 Thermo Fisher Scientific Inc Major Business
2.6.3 Thermo Fisher Scientific Inc IVF Product and Solutions
2.6.4 Thermo Fisher Scientific Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.7 Genea Biomedx
2.7.1 Genea Biomedx Details
2.7.2 Genea Biomedx Major Business
2.7.3 Genea Biomedx IVF Product and Solutions
2.7.4 Genea Biomedx IVF Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genea Biomedx Recent Developments and Future Plans
2.8 Auxogyn, Inc
2.8.1 Auxogyn, Inc Details
2.8.2 Auxogyn, Inc Major Business
2.8.3 Auxogyn, Inc IVF Product and Solutions
2.8.4 Auxogyn, Inc IVF Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Auxogyn, Inc Recent Developments and Future Plans
2.9 Oxford Gene Technology
2.9.1 Oxford Gene Technology Details
2.9.2 Oxford Gene Technology Major Business
2.9.3 Oxford Gene Technology IVF Product and Solutions
2.9.4 Oxford Gene Technology IVF Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Oxford Gene Technology Recent Developments and Future Plans
2.10 Ovascience
2.10.1 Ovascience Details
2.10.2 Ovascience Major Business
2.10.3 Ovascience IVF Product and Solutions
2.10.4 Ovascience IVF Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ovascience Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global IVF Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IVF by Company Revenue
3.2.2 Top 3 IVF Players Market Share in 2023
3.2.3 Top 6 IVF Players Market Share in 2023
3.3 IVF Market: Overall Company Footprint Analysis
3.3.1 IVF Market: Region Footprint
3.3.2 IVF Market: Company Product Type Footprint
3.3.3 IVF Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global IVF Consumption Value and Market Share by Type (2019-2024)
4.2 Global IVF Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global IVF Consumption Value Market Share by Application (2019-2024)
5.2 Global IVF Market Forecast by Application (2025-2030)
6 North America
6.1 North America IVF Consumption Value by Type (2019-2030)
6.2 North America IVF Consumption Value by Application (2019-2030)
6.3 North America IVF Market Size by Country
6.3.1 North America IVF Consumption Value by Country (2019-2030)
6.3.2 United States IVF Market Size and Forecast (2019-2030)
6.3.3 Canada IVF Market Size and Forecast (2019-2030)
6.3.4 Mexico IVF Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe IVF Consumption Value by Type (2019-2030)
7.2 Europe IVF Consumption Value by Application (2019-2030)
7.3 Europe IVF Market Size by Country
7.3.1 Europe IVF Consumption Value by Country (2019-2030)
7.3.2 Germany IVF Market Size and Forecast (2019-2030)
7.3.3 France IVF Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IVF Market Size and Forecast (2019-2030)
7.3.5 Russia IVF Market Size and Forecast (2019-2030)
7.3.6 Italy IVF Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific IVF Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IVF Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IVF Market Size by Region
8.3.1 Asia-Pacific IVF Consumption Value by Region (2019-2030)
8.3.2 China IVF Market Size and Forecast (2019-2030)
8.3.3 Japan IVF Market Size and Forecast (2019-2030)
8.3.4 South Korea IVF Market Size and Forecast (2019-2030)
8.3.5 India IVF Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IVF Market Size and Forecast (2019-2030)
8.3.7 Australia IVF Market Size and Forecast (2019-2030)
9 South America
9.1 South America IVF Consumption Value by Type (2019-2030)
9.2 South America IVF Consumption Value by Application (2019-2030)
9.3 South America IVF Market Size by Country
9.3.1 South America IVF Consumption Value by Country (2019-2030)
9.3.2 Brazil IVF Market Size and Forecast (2019-2030)
9.3.3 Argentina IVF Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa IVF Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IVF Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IVF Market Size by Country
10.3.1 Middle East & Africa IVF Consumption Value by Country (2019-2030)
10.3.2 Turkey IVF Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IVF Market Size and Forecast (2019-2030)
10.3.4 UAE IVF Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 IVF Market Drivers
11.2 IVF Market Restraints
11.3 IVF Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 IVF Industry Chain
12.2 IVF Upstream Analysis
12.3 IVF Midstream Analysis
12.4 IVF Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂